Medical treatment of obstructive sleep apnea

Seminars in Respiratory and Critical Care Medicine

Volumn 26, Issue 1, 2005, Pages 96-108

  Qureshi, Asher ^a,b   Lee Chiong Jr , Teofilo L ^c,d  

^a SAINT FRANCIS HOSPITAL AND MEDICAL CENTER   (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

^c NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^d UNIVERSITY OF COLORADO   (United States)

Author keywords

Obstructive sleep apnea; Oxygen therapy; Pharmacological treatment of sleep apnea; Positional therapy; Weight reduction

Indexed keywords

ACETAZOLAMIDE; ALMITRINE; AMINOPHYLLINE; ANTIDEPRESSANT AGENT; BACLOFEN; BENZODIAZEPINE DERIVATIVE; BUPIVACAINE; CLOMIPRAMINE; ESTROGEN; FLUOXETINE; FLURAZEPAM; GESTAGEN; HYDROMORPHONE; IMIPRAMINE; MEDROXYPROGESTERONE; MORPHINE; MUSCLE RELAXANT AGENT; NARCOTIC AGENT; NITRAZEPAM; PAROXETINE; PROTRIPTYLINE; RESPIRATORY STIMULANT AGENT; TEMAZEPAM; THEOPHYLLINE; THYROID HORMONE; TRAZODONE; TRIAZOLAM; UNINDEXED DRUG; ZOLPIDEM; ZOPICLONE;

CLINICAL TRIAL; DRUG EFFICACY; HUMAN; HYPOGLOSSAL NERVE; LUNG COMPLIANCE; MUSCLE TONE; NERVE STIMULATION; OXYGEN THERAPY; PATIENT POSITIONING; PRIORITY JOURNAL; REM SLEEP; REVIEW; SKELETAL MUSCLE; SLEEP; SLEEP APNEA SYNDROME; WAKEFULNESS; WEIGHT REDUCTION;

ANTIDEPRESSIVE AGENTS; CONTINUOUS POSITIVE AIRWAY PRESSURE; HUMANS; MEDROXYPROGESTERONE; PHOSPHODIESTERASE INHIBITORS; POSTURE; RESPIRATORY SYSTEM AGENTS; SLEEP APNEA, OBSTRUCTIVE; THEOPHYLLINE; WEIGHT LOSS;

EID: 14644407537     PISSN: 10693424     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-864203     Document Type: Review

References (131)

1. George CF, Millar TW, Kryger MH. Sleep apnea and body position during sleep. Sleep 1988;11:90-99
2. Cartwright RD. Effect of sleep position on sleep apnea severity. Sleep 1984;7:110-114
3. Jokic R, Klimaszewski A, Crossley M, Sridhar G, Fitzpatrick MF. Positional treatment vs continuous positive airway pressure in patients with positional bstructive sleep apnea syndrome. Chest 1999;115:771-781
4. Fransson AM, Svenson BA, Isacsson G. The effect of posture and a mandibular protruding device on pharyngeal dimensions: a cephalometric study. Sleep Breath 2002;6:55-68
5. Yoshida K. Influence of sleep posture on response to oral appliance therapy for sleep apnea syndrome. Sleep 2001;24:538-544
6. Bahammam AS, Tate R, Manfreda J, Kryger MH. Upper airway resistance syndrome: effect of nasal dilation, sleep stage, and sleep position. Sleep 1999;22:592-598
7. Neil A, Ignacio E, Shaharuddin N, Sajkov D. Upper body elevation improves upper airway stability but not indices of severity in obstructive sleep apnea syndrome. Aust N Z J Med 1998;28:270
8. Neill AM, Angus SM, Sajkov D, McEvoy RD. Effects of sleep posture on upper airway stability in patients with obstructive sleep apnea. Am J Respir Crit Care Med 1997;155:199-204
9. Penzel T, Moller M, Becker HF, Knaack L, Peter JH. Effect of sleep position and sleep stage on the collapsibility of the upper airways in patients with sleep apnea. Sleep 2001;24:90-95
10. Cartwright R, Ristanovic R, Diaz F, Caldarelli D, Alder G. A comparative study of treatments for positional sleep apnea. Sleep 1991;14:546-552
11. Cartwright R, Lloyd S, Lilie J, Kravitz H. Sleep position training as treatment for sleep apnea syndrome: a preliminary study. Sleep 1985;8:87-94
12. Katz I, Stradling J, Slutsky AS, Zamel N, Hoffstein V. Do patients with obstructive sleep apnea have thick necks? Am Rev Respir Dis 1990;141:1228-1231
13. Ryan CF, Love LL. Mechanical properties of the velopharynx in obese patients with obstructive sleep apnea. Am J Respir Crit Care Med 1996;154:806-812
14. Schwab R, Gefter W, Hoffman E, Gupta KB, Pack AI. Dynamic upper airway imaging during awake respiration in normal subjects and patients with sleep disordered breathing. Am Rev Respir Dis 1993;148:1385-1400
15. Horner RL, Mohiaddin RH, Lowell DG, et al. Sites and sizes of fat deposits around the pharynx in obese patients with obstructive sleep apnoea and weight matched controls. Eur Respir J 1989;2:613-622
16. Suratt P, McTier R, Wilhoit SC. Collapsibility of the nasopharyngeal airway in obstructive sleep apnea. Am Rev Respir Dis 1985;132:967-971
17. Schwartz AR, Gold AR, Schubert N, et al. Effect of weight loss on upper airway collapsibility in obstructive sleep apnea. Am Rev Respir Dis 1991;144:494-498
18. Browman CP, Sampson MG, Yolles SF, et al. Obstructive sleep apnea and body weight. Chest 1984;85:435-436
19. Smith PL, Gold AR, Meyers DA, Haponik EF, Bleecker ER. Weight loss in mildly to moderately obese patients with obstructive sleep apnea. Ann Intern Med 1985;103:850-855
20. Peppard PE, Young T, Palta M, Dempsey J, Skatrud J. Longitudinal study of moderate weight change and sleep disordered breathing. JAMA 2000;284:3015-3021
21. Lojander J, Mustajoki P, Ronka S, Mecklin P, Maasilta P. A nurse-managed weight reduction programme for obstructive sleep apnoea syndrome. J Intern Med 1998;244:251-255
22. Pasquali R, Colella P, Cirignotta F, et al. Treatment of obese patients with obstructive sleep apnea syndrome(OSAS): effect of weight loss and interference of otorhinolaryngoiatric pathology. Int J Obes 1990;14:207-217
23. Suratt PM, McTier RE, Findley LJ, Pohl SL, Wilhoit SC. Effect of very-low calorie diets with weight loss on obstructive sleep apnea. Am J Clin Nutr 1992;56(suppl): 182S-184S
24. Kansanen M, Vanninen E, Tuunainen A, et al. The effect of very low-calorie diet-induced weight loss on the severity of obstructive sleep apnoea and autonomic nervous function in obese patients with obstructive sleep apnoea syndrome. Clin Physiol 1998;18:377-385
25. Sugerman HJ, Fairman RP, Sood RK, Engle K, Wolfe L, Kellum JM. Long-term effects of gastric surgery for treating respiratory insufficiency of obesity. Am J Clin Nutr 1992;55:597S-601S
26. Harman EM, Wynne JW, Block AJ. The effect of weight loss on sleep disordered breathing and oxygen desaturation in morbidly obese men. Chest 1982;82:291-294
27. Charuzi I, Ovnat A, Peiser J, Saltz H, Weitzman S, Lavie P. The effect of surgical weight reduction on sleep quality in obesity-related sleep apnea syndrome. Surgery 1985;97:535-538
28. Scheuller M, Weider D. Bariatric surgery for treatment of sleep apnea syndrome in 15 morbidly obese patients: long-term results. Otolaryngol Head Neck Surg 2001;125:299-302
29. NIH Technology Assessment Conference Panel. Methods for voluntary weight loss and control. Ann Intern Med 1993;119:764-770
30. Garner D, Wooley S. Confronting the failure of behavioural and dietary treatment for obesity. Clin Psychol Rev 1991;11:729-780
31. Sampol G, Munoz X, Sagales MT, et al. Long-term efficacy of dietary weight loss in sleep apnoea/hypopnoea syndrome. Eur Respir J 1998;12:1156-1159
32. Pillar G, Peled R, Lavie P. Recurrence of sleep apnea without concomitant weight increase 7.5 years after weight reduction surgery. Chest 1994;106:1702-1704
33. Loube DI, Loube AA, Mitler MM. Weight loss for obstructive sleep apnea: the optimal therapy for obese patients. J Am Diet Assoc 1994;94:1291-1295
34. Stradling J, Roberts D, Wilson A, Lovelock F. Controlled trial of hypnotherapy for weight loss in patients with obstructive sleep apnoea. Int J Obes Relat Metab Disord 1998;22:278-281
35. Mayos M, Hernandez Plaza L, Farre A, Mota S, Sanchis J. The effect of nocturnal oxygen therapy in patients with sleep apnea syndrome and chronic airflow limitation. Arch Bronconeumol 2001;37:65-68
36. Marcus CL, Carroll JL, Bamford O, Pyzik P, Loughlin GM. Supplemental oxygen during sleep in children with sleep-disordered breathing. Am J Respir Crit Care Med 1995;152(4 Pt 1):1297-1301
37. Phillips BA, Schmitt FA, Berry DT, Lamb DG, Amin M, Cook YR. Treatment of obstructive sleep apnea. A preliminary report comparing nasal CPAP to nasal oxygen in patients with mild OSA. Chest 1990;98:325-330
38. Staniforth AD, Kinnear WJ, Starling R, Hetmanski DJ, Cowley AJ. Effect of oxygen on sleep quality, cognitive function and sympathetic activity in patients with chronic heart failure and Cheyne-Stokes respiration. Eur Heart J 1998;19:922-928
39. Gold AR, Schwartz AR, Bleecker ER, Smith PL. The effect of chronic nocturnal oxygen administration upon sleep apnea. Am Rev Respir Dis 1986;134:925-929
40. Marrone O, Bellia V, Pieri D, Salvaggio A, Bonsignore G. Acute effects of oxygen administration on transmural pulmonary artery pressure in obstructive sleep apnea. Chest 1992;101:1023-1027
41. Chauncey JB, Aldrich MS. Preliminary findings in the treatment of obstructive sleep apnea with transtracheal oxygen. Sleep 1990;13:167-174
42. Finnimore AJ, Roebuck M, Sajkov D, McEvoy RD. The effects of the GABA agonist, baclofen, on sleep and breathing. Eur Respir J 1995;8:230-234
43. Dolly FR, Block AJ. Effect of flurazepam on sleep-disordered breathing and nocturnal oxygen desaturation in asymptomatic subjects. Am J Med 1982;73:239-243
44. Ancoli-Israel S, Kripke DF, Zorick F, Roth T. Effects of a single dose of flurazepam on the sleep of healthy volunteers. Arzneimittelforschung 1984;34:99-100
45. Hoijer U, Hedner J, Ejnell H, Grunstein R, Odelberg E, Elam M. Nitrazepam in patients with sleep apnoea: a double-blind placebo-controlled study. Eur Respir J 1994;7:2011-2015
46. Camacho ME, Morin CM. The effect of temazepam on respiration in elderly insomniacs with mild sleep apnea. Sleep 1995;18:644-645
47. Berry RB, Kouchi K, Bower J, Prosise G, Light RW. Triazolam in patients, with obstructive sleep apnea. Am J Respir Crit Care Med 1995;151(2 Pt 1):450-454
48. Clyburn PA, Rosen M, Vickers MD. Comparison of the respiratory effects of I.V. infusions of morphine and regional analgesia by extradural block. BJA. Br J Anaesth 1990;64:446-449
49. Robinson RW, Zwillich CW, Bixler EO, Cadieux RJ, Kales A, White DP. Effects of oral narcotics on sleep-disordered breathing in healthy adults. Chest 1987;91:197-203
50. Steens RD, Pouliot Z, Millar TW, Kryger MH, George CF. Effects of zolpidem and triazolam on sleep and respiration in mild to moderate chronic obstructive pulmonary disease. Sleep 1993;16:318-326
51. Lofaso F, Goldenberg F, Thebault C, Janus C, Harf A. Effect of zopiclone on sleep, night-time ventilation, and daytime vigilance in upper airway resistance syndrome. Eur Respir J 1997;10:2573-2577
52. Tojima H, Kunitomo F, Kimura H, Tatsumi K, Kuriyama T, Honda Y. Effects of acetazolamide in patients with the sleep apnoea syndrome. Thorax 1988;43:113-119
53. Whyte KF, Gould GA, Airlie MA, Shapiro CM, Douglas NJ. Role of protriptyline and acetazolamide in the sleep apnea/hypopnea syndrome. Sleep 1988;11:463-472
54. Sakamoto T, Nakazawa Y, Hashizume Y, et al. Effects of acetazolamide on the sleep apnea syndrome and its therapeutic mechanism. Psychiatry Clin Neurosci 1995;49:59-64
55. Inoue Y, Takata K, Sakamoto I, Hazama H, Kawahara R. Clinical efficacy and indication of acetazolamide treatment on sleep apnea syndrome. Psychiatry Clin Neurosci 1999;53:321-322
56. Guilleminault C, Silvestri R, Mondini S, Coburn S. Aging and sleep apnea: action of benzodiazepine, acetazolamide, alcohol, and sleep deprivation in a healthy elderly group. J Gerontol 1984;39:655-661
57. Mangin P, Krieger J, Kurtz D. Effect of oral almitrine on the sleep apnea syndrome. Rev Fr Mal Respir 1983;11:899-906
58. Marrone O, Milone F, Coppola P, et al. Effects of almitrine bismesylate on nocturnal hypoxemia in patients with chronic bronchitis and obesity. Eur J Respir Dis Suppl 1986;146:641-648
59. Block AJ, Wynne JW, Boysen PG, Lindsey S, Martin C, Cantor B. Menopause, medroxyprogesterone and breathing during sleep. Am J Med 1981;70:506-510
60. Strohl KP, Hensley MJ, Saunders NA, Scharf SM, Brown R, Ingram RH Jr. Progesterone administration and progressive sleep apneas. JAMA 1981;245:1230-1232
61. Kimura H, Tatsumi K, Kunitomo F, et al. Progesterone therapy for sleep apnea syndrome evaluated by occlusion pressure responses to exogenous loading. Am Rev Respir Dis 1989;139:1198-1206
62. Ohshima H. Medroxyprogesterone acetate and sleep apnea. Jpn J Psychiatry Neurol 1987;41:645-650
63. Watanabe T, Mikami A, Motonishi M, et al. Two cases of sleep-disordered breathing in climacteric. Psychiatry Clin Neurosci 1998;52:231-232
64. Rajagopal KR, Abbrecht PH, Jabbari B. Effects of medroxyprogesterone acetate in obstructive sleep apnea. Chest 1986;90:815-821
65. Cook WR, Benich JJ, Wooten SA. Indices of severity of obstructive sleep apnea syndrome do not change during medroxyprogesterone acetate therapy. Chest 1989;96:262-266
66. Dolly FR, Block AJ. Medroxyprogesterone acetate and COPD. Effect on breathing and oxygenation in sleeping and awake patients. Chest 1983;84:394-398
67. Saaresranta T, Polo-Kantola P, Rauhala E, Polo O. Medroxyprogesterone in postmenopausal females with partial upper airway obstruction during sleep. Eur Respir J 2001;18:989-995
68. Keefe DL, Watson R, Naftolin F. Hormone replacement therapy may alleviate sleep apnea in menopausal women: a pilot study. Menopause 1999;6:196-200
69. Pickett CK, Regensteiner JG, Woodard WD, Hagerman DD, Weil JV, Moore LG. Progestin and estrogen reduce sleep-disordered breathing in postmenopausal women. J Appl Physiol 1989;66:1656-1661
70. Cistulli PA, Barnes DJ, Grunstein RR, Sullivan CE. Effect of short-term hormone replacement in the treatment of obstructive sleep apnoea in postmenopausal women. Thorax 1994;49:699-702
71. Krieger J, Mangin P, Kurtz D. Sleep apnea synrome: effects of chlorimipramine in subjects with stable body weight. Rev Electroencephalogr Neurophysiol Clin 1979;9:250-257
72. Esnault-Lavandier S, Mabin D. The effects of clomipramine on diurnal sleepiness and respiratory parameters in a a case of Prader-Willi syndrome. Neurophysiol Clin 1998;28:521-525
73. Rubin AH, Alroy GG, Peled R, Lavie P. Preliminary clinical experience with imipramine HCl in the treatment of sleep apnea syndrome. Eur Neurol 1986;25:81-85
74. Sunderram J, Parisi RA, Strobel RJ. Serotonergic stimulation of the genioglossus and the response to nasal continuous positive airway pressure. Am J Respir Crit Care Med 2000;162(3 Pt 1):925-929
75. Berry RB, Yamaura EM, Gill K, Reist C. Acute effects of paroxetine on genioglossus activity in obstructive sleep apnea. Sleep 1999;22:1087-1092
76. Kraiczi H, Hedner J, Dahlof P, Ejnell H, Carlson J. Effect of serotonin uptake inhibition on breathing during sleep and daytime symptoms in obstructive sleep apnea. Sleep 1999;22:61-67
77. Brownell LG, West P, Sweatman P, Acres JC, Kryger MH. Protriptyline in obstructive sleep apnea: a double-blind trial. N Engl J Med 1982;307:1037-1042
78. Brownell LG, Perez-Padilla R, West P, Kryger MH. The role of protriptyline in obstructive sleep apnea. Bull Eur Physiopathol Respir 1983;19:621-624
79. Hanzel DA, Proia NG, Hudgel DW. Response of obstructive sleep apnea to fluoxetine and protriptyline. Chest 1991;100:416-421
80. Whyte KF, Gould GA, Airlie MA, Shapiro CM, Douglas NJ. Role of protriptyline and acetazolamide in the sleep apnea/hypopnea syndrome. Sleep 1988;11:463-472
81. Conway WA, Zorick F, Piccione P, Roth T. Protriptyline in the treatment of sleep apnoea. Thorax 1982;37:49-53
82. Smith PL, Haponik EF, Allen RP, Bleecker ER. The effects of protriptyline in sleep-disordered breathing. Am Rev Respir Dis 1983;127:8-13
83. Hanzel DA, Proia NG, Hudgel DW. Response of obstructive sleep apnea to fluoxetine and protriptyline. Chest 1991;100:416-421
84. Veasey SC, Fenik P, Panckeri K, Pack AI, Hendricks JC. The effects of trazodone with L-tryptophan on sleep-disordered breathing in the English bulldog. Am J Respir Crit Care Med 1999;160(5 Pt 1):1659-1667
85. Salazar-Grueso EF, Rosenberg RS, Roos RP. Sleep apnea in olivopontocerebellar degeneration: treatment with trazodone. Ann Neurol 1988;23:399-401
86. Chiang CH, Tang YC, Wang SE, Hwang JC. Changes in phrenic, hypoglossal and recurrent laryngeal nerve activities after intravenous infusions of aminophylline in cats. Eur Respir J 1995;8:632-636
87. Schafer HH, Grieger E, Heitmann J, et al. Long-term theophylline therapy in sleep apnea-follow-up over a period of 12 months. Pneumologie 1993;47(Suppl 4):741-746
88. Meissner P, Dorow P, Thalhofer S, Heinemann S. Theophylline acceptance in long-term therapy of patients with obstructive sleep related respiratory disorder. Pneumologie 1995;49(Suppl 1):187-189
89. Hein H, Kirsten D, Jugert C, Magnussen H. Theophylline in therapy of obstructive sleep apnea? Pneumologie 1993;47(Suppl 4):750-753
90. Guilleminault C, Hayes B. Naloxone, theophylline, bromocriptine, and obstructive sleep apnea. Negative results. Bull Eur Physiopathol Respir 1983;19:632-634
91. Espinoza H, Antic R, Thornton AT, McEvoy RD. The effects of aminophylline on sleep and sleep-disordered breathing in patients with obstructive sleep apnea syndrome. Am Rev Respir Dis 1987;136:80-84
92. Oberndorfer S, Saletu B, Gruber G, et al. Theophylline in snoring and sleep-related breathing disorders: sleep laboratory investigations on subjective and objective sleep and awakening quality. Methods Find Exp Clin Pharmacol 2000;22:237-245
93. Tschida U, Winkler A. Efficiency of continuous positive airway pressure versus theophylline therapy in sleep apnea: comparative sleep laboratory studies on objective and subjective sleep and awakening quality. Neuropsychobiology 1999;39:151-159
94. Kempf P, Mossinger B, Muller B, Kirchheiner T, Ruhle KH. Comparative studies on the effect of nasal CPAP, theophylline and oxygen in patients with sleep apnea syndrome. Pneumologie 1991;45(Suppl 1):279-282
95. Di Martino E, Saadi R, Emmerling O, Werner E. Drug therapy of sleep apnea syndromes: results of short-term treatment with theophylline. Laryngorhinootologie 1999;78:120-124
96. Mulloy E, McNicholas WT. Theophylline in obstructive sleep apnea. A double-blind evaluation. Chest 1992;101:753-757
97. Berry RB, Desa MM, Branum JP, Light RW. Effect of theophylline on sleep and sleep-disordered breathing in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1991;143:245-250
98. Teramoto S, Ohga E, Katayama H, et al. Effects of thyroid hormone replacement therapy on nocturnal apnea in elderly patients with hypothyroidism. Nihon Kokyuki Gakkai Zasshi 1998;36:590-594
99. Bai Y. Primary hypothyroidism with obstructive sleep apnea syndrome. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 1992;14:267-272
100. Ziemer DC, Dunlap DB. Relief of sleep apnea in acromegaly by bromocriptine. Am J Med Sci 1988;295:49-51
101. Guilleminault C, Hayes B. Naloxone, theophylline, bromocriptine, and obstructive sleep apnea: negative results. Bull Eur Physiopathol Respir 1983;19:632-634
102. Davis JM, Zinman R, Aranda JV. Use of caffeine in the treatment, of apnea associated with the Arnold-Chiari malformation. Dev Pharmacol Ther 1989;12:70-73
103. Carley DW, Paviovic S, Janelidze M, Radulovacki M. Functional role for cannabinoids in respiratory stability during sleep. Sleep 2002;25:391-398
104. Mayer J, Peter JH. First experience with cilazapril in the treatment of sleep apnoea-related hypertension. Drugs 1991;41(Suppl 1):37-47
105. Peter JH, Gassel W, Mayer J, et al. Effect of cilazapril on hypertension, sleep, and apnea. Am J Med 1989;87(Suppl 6B):72S-78S
106. Grote L, Wutkewicz K, Knaack L, Ploch T, Hedner J, Peter JH. Association between blood pressure reduction with antihypertensive treatment and sleep apnea activity. Am J Hypertens 2000;13:1280-1287
107. Issa FG. Effect of clonidine in obstructive sleep apnea. Am Rev Respir Dis 1992;145(2 Pt 1):435-439
108. Osanai S, Akiba Y, Fujiuchi S, et al. Depression of peripheral chemosensitivity by a dopaminergic mechanism in patients with obstructive sleep apnoea syndrome. Eur Respir J 1999;13:418-423
109. Suratt PM, Wilhoit SC, Brown ED, Findley LJ. Effect of doxapram on obstructive sleep apnea. Bull Eur Physiopathol Respir 1986;22:127-131
110. Schmidt HS. L-tryptophan in the treatment of impaired respiration in sleep. Bull Eur Physiopathol Respir 1983;19:625-629
111. Pack AI, Black JE, Schwartz JR, Matheson JK. Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea. Am J Respir Crit Care Med. 2001;64:1675-1681
112. Arnulf I, Homeyer P, Garma L, Whitelaw WA, Derenne JP. Modafinil in obstructive sleep apnea-hypopnea syndrome: a pilot study in 6 patients. Respiration 1997;64:159-161
113. Kingshott RN, Vennelle M, Coleman EL, Engleman HM, Mackay TW, Douglas NJ. Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of residual excessive daytime sleepiness in the sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med 2001;163:918-923
114. Guilleminault C, Hayes B. Naloxone, theophylline, bromocriptine, and obstructive sleep apnea. Negative results. Bull Eur Physiopathol Respir 1983;19:632-634
115. Haidmayer R, Kerbl R, Meyer U, Kerschhaggl P, Kurz R, Kenner T. Effects of naloxone on apnoea duration during sleep in infants at risk for SIDS. Eur J Pediatr 1986;145:357-360
116. Ferber C, Sanchez P, Lemoine P, Mouret J. Efficacy of the treatment of sleep apnea using naltrexone: a clinical, polygraphic and gasometric study. C R Acad Sci III 1988;307:695-700
117. Ferber C, Duclaux R, Mouret J. Naltrexone improves blood gas patterns in obstructive sleep apnoea syndrome through its influence on sleep. J Sleep Res 1993;2:149-155
118. Davila DG, Hurt RD, Offord KP, Harris CD, Shepard JW Jr. Acute effects of transdermal nicotine on sleep architecture, snoring, and sleep-disordered breathing in nonsmokers. Am J Respir Crit Care Med 1994;150:469-474
119. Gothe B, Strohl KP, Levin S, Cherniack NS. Nicotine: a different approach to treatment of obstructive sleep apnea. Chest 1985;87:11-17
120. Wirth JA. Organic psychosyndrome and sleep apnea: transdermal nicotine - a new therapy concept? Pneumologie 1995;49(Suppl 1):183-184
121. Hein H, Kirsten D, Jugert C, Magnussen H. Nicotine as therapy of obstructive sleep apnea? Pneumologie 1995;49(Suppl 1):185-186
122. Veasey SC, Chachkes J, Fenik P, Hendricks JC. The effects of ondansetron on sleep-disordered breathing in the English bulldog. Sleep 2001;24:155-160
123. Hedner J, Grunstein R, Eriksson B, Ejnell H. A double-blind, randomized trial of sabeluzole: a putative glutamate antagonist in obstructive sleep apnea. Sleep 1996;19:287-289
124. Ip MS, Tan KC, Peh WC, Lam KS. Effect of Sandostatin LAR on sleep apnoea in acromegaly: correlation with computerized tomographic cephalometry and hormonal activity. Clin Endocrinol (Oxf) 2001;55:477-483
125. Esnault S, Merceur C, Kerlan V, et al. Long-term effects of treatment with SMS 201-995 on sleep apnea syndrome associated with acromegaly. Neurophysiol Clin 1989;19:367-372
126. Grunstein RR, Ho KK, Sullivan CE. Effect of octreotide, a somatostatin analog, on sleep apnea in patients with acromegaly. Ann Intern Med 1994;121:478-483
127. Brouillette RT, Manoukian JJ, Ducharme FM, et al. Efficacy of fluticasone nasal spray for pediatric obstructive sleep apnea. J Pediatr 2001;138:838-844
128. Guilleminault C, Powell N, Bowman B, Stoohs R. The effect of electrical stimulation on obstructive sleep apnea. Chest 1995;107:67-73
129. Goding GS Jr, Eisele DW, Testerman R, Smith PL, Roertgen K, Schwartz AR. Relief of upper airway obstruction with hypoglossal nerve stimulation in the canine. Laryngoscope 1998;108:162-169
130. Eisele DW, Smith PL, Alam DS, Schwartz AR. Direct hypoglossal nerve stimulation in obstructive sleep apnea. Arch Otolaryngol Head Neck Surg 1997;123:57-61
131. Hoijer U, Ejnell H, Hedner J, Petruson B, Eng LB. The effects of nasal dilation on snoring and obstructive sleep apnea. Arch Otolaryngol Head Neck Surg 1992;118:281-284